Pharmacogenomics of essential hypertension: are we going the right way?
about
Genetic factors are relevant and independent determinants of antihypertensive drug effects in a multiracial populationPharmacogenetics of antihypertensive treatment: detailing disciplinary dissonanceImpact of a novel mutation in the 5'-flanking region of natriuretic peptide precursor B gene on the antihypertensive effects of sodium nitroprusside in patients with hypertension.Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study.Pharmacogenomics and antihypertensive drugs: a path toward personalized medicine
P2860
Pharmacogenomics of essential hypertension: are we going the right way?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Pharmacogenomics of essential hypertension: are we going the right way?
@ast
Pharmacogenomics of essential hypertension: are we going the right way?
@en
type
label
Pharmacogenomics of essential hypertension: are we going the right way?
@ast
Pharmacogenomics of essential hypertension: are we going the right way?
@en
prefLabel
Pharmacogenomics of essential hypertension: are we going the right way?
@ast
Pharmacogenomics of essential hypertension: are we going the right way?
@en
P2093
P1476
Pharmacogenomics of essential hypertension: are we going the right way?
@en
P2093
Filigheddu F
Glorioso N
P356
10.2174/187152506775268749
P577
2006-01-01T00:00:00Z